| Conţinutul numărului revistei |
| Articolul precedent |
| Articolul urmator |
 |
 1050 9 |
| Ultima descărcare din IBN: 2023-06-07 08:58 |
 SM ISO690:2012ONU, Vera, CASAPCIUC, Marina, SEREBREANSCHI, Iraida, CALPAC, Vladimir. Eficacitatea noului preparat antihistaminic eslotin în tratamentul rinitei alergice. In: Analele Ştiinţifice ale USMF „N. Testemiţanu”, 2011, nr. 3(12), pp. 264-268. ISSN 1857-1719. |
| EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
| Analele Ştiinţifice ale USMF „N. Testemiţanu” | ||||||
| Numărul 3(12) / 2011 / ISSN 1857-1719 | ||||||
|
||||||
| Pag. 264-268 | ||||||
|
||||||
 Descarcă PDF |
||||||
| Rezumat | ||||||
Effectiveness of new antihistamine drug Eslotin in treatment of allergic rhinitis
There have been studied the efficacy of Eslotin drug as basic treatment in allergic rhinitis.
Administration of Eslotin demonstrated antihistaminic qualitative activity, good clinical
efficiency which assured the control of allergic inflammation symptoms, compared with other
antihistamines, being determined by its pharmacologic particularities. |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-16149</cfResPublId> <cfResPublDate>2011-06-01</cfResPublDate> <cfVol>12</cfVol> <cfIssue>3</cfIssue> <cfStartPage>264</cfStartPage> <cfISSN>1857-1719</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/16149</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Eficacitatea noului preparat antihistaminic eslotin în tratamentul rinitei alergice</cfTitle> <cfAbstr cfLangCode='EN' cfTrans='o'>Effectiveness of new antihistamine drug Eslotin in treatment of allergic rhinitis There have been studied the efficacy of Eslotin drug as basic treatment in allergic rhinitis. Administration of Eslotin demonstrated antihistaminic qualitative activity, good clinical efficiency which assured the control of allergic inflammation symptoms, compared with other antihistamines, being determined by its pharmacologic particularities.</cfAbstr> <cfAbstr cfLangCode='RO' cfTrans='o'>A fost studiat efectul preparatului Eslotin în calitate de terapie de bază în rinita alergică. Administrarea Eslotinei a demonstrat o activitate antihistaminică calitativă, eficacitate clinică înaltă ce asigură controlul asupra simptomelor inflamaţiei alergice, comparativ cu alte antihistaminice, aceste proprietăţi fiind determinate de particularităţile sale farmacologice.</cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2011-06-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2011-06-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-11450</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2011-06-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-13446</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2011-06-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-42688</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2011-06-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-35942</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2011-06-01T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-11450</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11450-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2011-06-01T24:00:00</cfStartDate> <cfFamilyNames>Onu</cfFamilyNames> <cfFirstNames>Vera</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-13446</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-13446-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2011-06-01T24:00:00</cfStartDate> <cfFamilyNames>Casapciuc</cfFamilyNames> <cfFirstNames>Marina</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-42688</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-42688-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2011-06-01T24:00:00</cfStartDate> <cfFamilyNames>Serebreanschi</cfFamilyNames> <cfFirstNames>Iraida</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-35942</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-35942-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2011-06-01T24:00:00</cfStartDate> <cfFamilyNames>Calpac</cfFamilyNames> <cfFirstNames>Vladimir</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>
|
|
|
